JP2021525730A5 - - Google Patents
Info
- Publication number
- JP2021525730A5 JP2021525730A5 JP2020566662A JP2020566662A JP2021525730A5 JP 2021525730 A5 JP2021525730 A5 JP 2021525730A5 JP 2020566662 A JP2020566662 A JP 2020566662A JP 2020566662 A JP2020566662 A JP 2020566662A JP 2021525730 A5 JP2021525730 A5 JP 2021525730A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- pharmaceutically acceptable
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862677498P | 2018-05-29 | 2018-05-29 | |
| US62/677,498 | 2018-05-29 | ||
| PCT/IB2019/000691 WO2019229536A2 (en) | 2018-05-29 | 2019-05-29 | Novel benzodiazepine derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525730A JP2021525730A (ja) | 2021-09-27 |
| JP2021525730A5 true JP2021525730A5 (enExample) | 2022-06-07 |
| JP7465819B2 JP7465819B2 (ja) | 2024-04-11 |
Family
ID=68692822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566662A Active JP7465819B2 (ja) | 2018-05-29 | 2019-05-29 | 新規ベンゾジアゼピン誘導体及びそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11084801B2 (enExample) |
| EP (1) | EP3802546A4 (enExample) |
| JP (1) | JP7465819B2 (enExample) |
| KR (1) | KR102946423B1 (enExample) |
| CN (2) | CN113444111A (enExample) |
| AU (2) | AU2019276833A1 (enExample) |
| BR (1) | BR112020023623A2 (enExample) |
| CA (1) | CA3100141A1 (enExample) |
| EA (1) | EA202092909A1 (enExample) |
| IL (1) | IL278973B2 (enExample) |
| MX (1) | MX2020012718A (enExample) |
| WO (1) | WO2019229536A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120682290A (zh) | 2017-07-04 | 2025-09-23 | 尹图赛利有限公司 | 包含可裂解接头的化合物及其用途 |
| MX2020012718A (es) | 2018-05-29 | 2021-02-16 | Intocell Inc | Derivados de benzodiazepinas novedosos y usos de los mismos. |
| CN112930350A (zh) | 2018-10-31 | 2021-06-08 | 尹图赛利有限公司 | 稠合杂环苯并二氮杂䓬衍生物及其用途 |
| WO2020141459A1 (en) * | 2019-01-03 | 2020-07-09 | Intocell, Inc. | Compounds comprising cleavable linker and uses thereof |
| KR20210099658A (ko) | 2019-01-03 | 2021-08-12 | 주식회사 인투셀 | 절단가능 링커를 포함하는 화합물 및 이의 용도 |
| KR20220108783A (ko) * | 2019-12-02 | 2022-08-03 | 주식회사 인투셀 | 분자 접합과 관련된 조성물 및 방법 |
| BR112022026401A2 (pt) * | 2020-06-26 | 2023-03-14 | Intocell Inc | Conjugados anticorpo-fármaco compreendendo anticorpos anti-b7-h3 |
| CN114805432A (zh) * | 2022-03-03 | 2022-07-29 | 西北工业大学 | 新型可光催化剪切的羧酸保护基及其氨基酸衍生物的制备方法 |
| CN119424671A (zh) | 2023-08-01 | 2025-02-14 | 上海新理念生物医药科技有限公司 | 含糖基吡啶型连接子的抗体药物偶联物 |
| WO2025262641A1 (en) * | 2024-06-19 | 2025-12-26 | Pheon Therapeutics Ltd | Antibody drug conjugates that bind cdcp1 and uses thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843937A (en) | 1996-05-23 | 1998-12-01 | Panorama Research, Inc. | DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| GB0819095D0 (en) * | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| RU2683325C2 (ru) | 2009-02-05 | 2019-03-28 | Иммьюноджен, Инк. | Новые производные бензодиазепина |
| CN103997893B (zh) | 2011-10-14 | 2019-04-12 | 西雅图基因公司 | 吡咯并苯并二氮杂卓和靶向结合物 |
| EP2751111B1 (en) * | 2011-10-14 | 2017-04-26 | MedImmune Limited | Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases |
| HK1211208A1 (zh) | 2012-08-22 | 2016-05-20 | Immunogen, Inc. | 細胞毒性苯並二氮呯衍生物 |
| CA2891280C (en) | 2012-11-24 | 2018-03-20 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules |
| WO2015095953A1 (en) * | 2013-12-27 | 2015-07-02 | The Centre For Drug Research And Development | Sulfonamide-containing linkage systems for drug conjugates |
| EP3160513B1 (en) | 2014-06-30 | 2020-02-12 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| MX2017009145A (es) * | 2015-01-14 | 2017-11-22 | Bristol Myers Squibb Co | Dimeros de benzodiazepina, conjugados de estos, y sus metodos de preparacion y uso. |
| BR112017014937A2 (pt) | 2015-01-14 | 2018-03-13 | Bristol-Myers Squibb Company | dímeros de benzodiazepina ligados em ponte a heteroarileno, conjugados dos mesmos, e métodos de preparação e uso |
| DK3270965T3 (da) | 2015-03-18 | 2020-06-08 | Seattle Genetics Inc | Cd48-antistoffer og konjugater deraf |
| US9504694B2 (en) | 2015-03-19 | 2016-11-29 | Cellerant Therapeutics, Inc. | Isoquinolidinobenzodiazepines |
| MA45054A (fr) | 2016-05-20 | 2019-03-27 | Abbvie Stemcentrx Llc | Conjugués médicament-anticorps dll3 pour le traitement de tumeurs à risque de transition neuroendocrinienne |
| WO2018053552A2 (en) * | 2016-09-19 | 2018-03-22 | Cellerant Therapeutics, Inc. | Isoquinolidinobenzodiazepines |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| KR102648564B1 (ko) * | 2017-03-24 | 2024-03-19 | 씨젠 인크. | 글루쿠로니드 약물-링커의 제조 공정 및 그 중간물 |
| WO2018195243A1 (en) | 2017-04-20 | 2018-10-25 | Immunogen, Inc. | Cytotoxic benzodiazepine derivatives and conjugates thereof |
| CN120682290A (zh) | 2017-07-04 | 2025-09-23 | 尹图赛利有限公司 | 包含可裂解接头的化合物及其用途 |
| GB201714115D0 (en) * | 2017-09-04 | 2017-10-18 | Femtogenix Ltd | Cytotoxic agents |
| MX2020012718A (es) | 2018-05-29 | 2021-02-16 | Intocell Inc | Derivados de benzodiazepinas novedosos y usos de los mismos. |
| CN112930350A (zh) | 2018-10-31 | 2021-06-08 | 尹图赛利有限公司 | 稠合杂环苯并二氮杂䓬衍生物及其用途 |
| KR102503143B1 (ko) | 2019-03-06 | 2023-02-24 | 주식회사 레고켐 바이오사이언스 | 인간 dlk1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| BR112022026401A2 (pt) | 2020-06-26 | 2023-03-14 | Intocell Inc | Conjugados anticorpo-fármaco compreendendo anticorpos anti-b7-h3 |
-
2019
- 2019-05-29 MX MX2020012718A patent/MX2020012718A/es unknown
- 2019-05-29 CN CN202110592302.2A patent/CN113444111A/zh active Pending
- 2019-05-29 CN CN201980035084.3A patent/CN112166115A/zh active Pending
- 2019-05-29 EA EA202092909A patent/EA202092909A1/ru unknown
- 2019-05-29 CA CA3100141A patent/CA3100141A1/en active Pending
- 2019-05-29 KR KR1020207037031A patent/KR102946423B1/ko active Active
- 2019-05-29 IL IL278973A patent/IL278973B2/en unknown
- 2019-05-29 JP JP2020566662A patent/JP7465819B2/ja active Active
- 2019-05-29 AU AU2019276833A patent/AU2019276833A1/en not_active Abandoned
- 2019-05-29 EP EP19811692.3A patent/EP3802546A4/en active Pending
- 2019-05-29 US US16/425,237 patent/US11084801B2/en active Active
- 2019-05-29 WO PCT/IB2019/000691 patent/WO2019229536A2/en not_active Ceased
- 2019-05-29 BR BR112020023623-3A patent/BR112020023623A2/pt unknown
-
2021
- 2021-06-30 US US17/363,814 patent/US11807628B2/en active Active
-
2023
- 2023-06-05 AU AU2023203485A patent/AU2023203485B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525730A5 (enExample) | ||
| JP2022510505A5 (enExample) | ||
| JP7229202B2 (ja) | 標的化薬物結合体と使用するためのメチレンカルバメートリンカー | |
| CN101909441B (zh) | 微管蛋白抑制剂及其制备方法 | |
| FI105155B (fi) | Menetelmä terapeuttisesti käyttökelpoisten sappihappojohdannaisten valmistamiseksi | |
| AU2017292522B2 (en) | Combination comprising EP4 antagonist and immune checkpoint inhibitor | |
| JP2025510629A (ja) | カンプトテシンコンジュゲート | |
| CN114053426B (zh) | 一种双药链接组装单元及双药靶向接头-药物偶联物 | |
| JP2023551355A (ja) | 抗腫瘍化合物並びにその調製方法及び使用 | |
| JP2022082777A (ja) | Ｐｅｇ化薬物リンカー及びその中間体を調製するためのプロセス | |
| JP2022529854A (ja) | カンプトテシン誘導体 | |
| JP2023105175A (ja) | グルクロニド薬物－リンカーの調製のためのプロセスおよびその中間体 | |
| MXPA05010471A (es) | Profarmacos inhibidores de quinasa pi-3. | |
| JP6929292B2 (ja) | 新規なクリプトフィシン化合物およびコンジュゲート、これらの製造およびこれらの治療用途 | |
| IL315310A (en) | Irak degraders and uses thereof | |
| US20090246211A1 (en) | Molecular constructs suitable for targeted conjugates | |
| KR20220052918A (ko) | 치료제로서의 사이토톡신의 펩티드 접합체 | |
| JP2006523237A5 (enExample) | ||
| KR20160045146A (ko) | 마크롤라이드 디아스테레오머를 포함하는 약제학적 조성물, 이의 합성 방법 및 치료학적 용도 | |
| CN105899515A (zh) | uncialamycin的衍生物、合成方法及其作为抗肿瘤剂的用途 | |
| JP2022515884A5 (enExample) | ||
| JP2018512424A (ja) | エステル化のための試薬及び方法 | |
| Makarov et al. | Modification of 3, 5-bis (arylidene)-4-piperidone pharmacophore by phosphonate group using 1, 2, 3-triazole cycle as a linker for the synthesis of new cytostatics | |
| JP2021531269A (ja) | チオシクロへプチン誘導体およびその使用 | |
| US11117907B2 (en) | Curcuminoid-inspired synthetic compounds as anti-tumor agents |